A new approach to T2 Diabetes
Type 2 diabetes can be hard to manage. Even with medication or lifestyle changes you may be at risk for health issues.
There may be another way.
Get the chance to receive an investigational treatment at no cost. The procedure can be done in about an hour and may improve blood sugar without increasing insulin or other medications.
*Must currently be taking basal insulin to qualify
See if You Qualify
Fill out the form below to see if you meet the basic study requirements.
To participate in the T2 diabetes study, you will need to:
What is the investigational treatment?
Revita®️ is a minimally invasive procedure that targets a portion of the small intestine called the duodenum to help control blood glucose levels. Studies have shown that treating the duodenum can improve type 2 diabetes. 1,2,3 Patients are asleep during the procedure, which lasts about one hour, and will be able to go home the same day and resume normal activities.
Frequently asked questions
Revitalize 1 is a clinical research study evaluating an exciting new procedure for type 2 diabetes that may improve blood sugar without increasing insulin or other medications. All eligible patients can receive the Revita® procedure and medical care related to the study at no cost.
Similar to how a medication study uses a placebo (sugar pill) for comparison, sham procedures are used in clinical trials so that results of the sham procedures can be compared with the results of the study procedure. Having a comparison allows for a clearer understanding of the investigational treatment results.
In the case of this clinical trial, those receiving the sham procedure would undergo many of the steps of the Revita® procedure but without the heating process used to remove the excess layer of the duodenum. But don’t worry! If you end up in the group receiving the sham procedure and are still considered eligible, you will be offered the opportunity to receive the Revita® procedure later in the study!
Yes. Participants may receive compensation for their participation which varies depending on location and more details on compensation may be provided by the study site.
Revita® is for investigational use only in the US.
1. van Baar et al. Gut. 2020; 69(2):295-303
2. van Baar et al. Diabetes Res Clin Pract.2022;12:109194
3. Mingrone et al. Gut. 2022; 71(2):254-264